579486-60-5

Basic information

• Product Name: 4,6-dichloro-2-methyl-3H-imidazo[4,5-c]pyridine
• Synonyms: 4,6-dichloro-2-methyl-3H-imidazo[4,5-c]pyridine;4,6-dichloro-2-methyl-1H-imidazo[4,5-c]pyridine(WX130445);4,6-DICHLORO-2-METHYL-1H-IMIDAZO[4,5-C]PYRIDINE
• CAS NO: 579486-60-5
• Molecular Formula: C₇H₅Cl₂N₃
• Molecular Weight: 202.0407
• Mol File: 579486-60-5.mol
• Article Data: 5

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 4,6-dichloro-2-methyl-3H-imidazo[4,5-c]pyridine(CAS DataBase Reference)
• NIST Chemistry Reference: 4,6-dichloro-2-methyl-3H-imidazo[4,5-c]pyridine(579486-60-5)
• EPA Substance Registry System: 4,6-dichloro-2-methyl-3H-imidazo[4,5-c]pyridine(579486-60-5)

Safety Data

• Hazardous Substances Data: 579486-60-5(Hazardous Substances Data)

Upstream product

• 2897-43-0 2,6-dichloro-3-nitropyridin-4-amine 
• 1445-45-0 Trimethyl orthoacetate 
• 101079-63-4 3,4-diamino-2,6-dichloropyridine 
• 2587-03-3 2,6-dichloro-N-nitro-4-pyridinamine 
• 2587-02-2 2,6-dichloro-[4]pyridylamine 
• 78-39-7 Triethyl orthoacetate 
• 64-19-7 acetic acid 

Downstream Products

• 1319732-00-7 7-(4-bromobutyl)-2-chloro-6-benzyloxy-8-methylimidazo[4,5-c]pyridine 
• 1319732-01-8 9-(4-bromobutyl)-2-chloro-6-benzyloxy-8-methylimidazo[4,5-c]pyridine 
• 1319732-02-9 7-(4-methoxybutyl)-2-chloro-6-benzyloxy-8-methylimidazo[4,5-c]pyridine 
• 1319732-03-0 9-(4-methoxybutyl)-2-chloro-6-benzyloxy-8-methylimidazo[4,5-c]pyridine 
• 579486-66-1 2-(3,4-dichlorobenzylamino)-7-(4-methoxybutyl)-8-methyl-6-oxo-3-deazapurine 
• 1319732-04-1 2-(3,4-dichlorobenzylamino)-9-(4-methoxybutyl)-8-methyl-6-oxo-3-deazapurine 
• 1319731-99-1 2-chloro-6-benzyloxy-8-methylimidazo[4,5-c]pyridine 

Relevant articles and documents

CDK INHIBITORS

Provided is a compound represented by structural formula (I), or a pharmaceutically acceptable salt, or a stereoisomer thereof useful for treating cancer.

AZABENZIMIDAZOLE DERIVATIVES AS PI3K BETA INHIBITORS

The present invention relates to azabenzimidazole derivatives of Formula (I) (I) wherein the variables have the meaning defined in the claims. The compounds according to the present invention are useful as pI3Kβ inhibitors. The invention further relates to pharmaceutical compositions comprising said compounds as an active 10 ingredient as well as the use of said compounds as a medicament.

Purine and isosteric antibacterial compounds

The invention features 2,7-disubstituted purines and their isosteres such as the corresponding 3-deazapurines and 3-deaza-8-azapurines. The compounds disclosed herein have potent anti-microbial, e.g., anti-bacterial and anti-mycoplasmal properties. The compounds described herein inhibit DNA polymerase IIIC and DNA polymerase IIIE species; the compounds thus inhibit the growth of bacteria and mycoplasmata. The compounds can be administered to prevent or to treat Gram-positive or Gram-negative bacterial or mycoplasmal infections, e.g., in eukaryotic cell cultures, animals, or humans.